Skip to content
★ Sign in to follow
케어랩스 logo

케어랩스 Stock: price and insider trades · South Korea

KR·Mcap ₩39.2BHealth Care

1 insider bought €61k of shares over the last 90 days, the latest by 원익홀딩스, filed 28 Sept 2026.

케어랩스: what insiders have been doing

케어랩스 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). In the past year (1 November 2025 to 1 November 2026), 7 filings came from 3 insiders.

No insider sold shares on the market over the period. Instead, the filings list 6 purchases, made by 2 insiders. No amount is published for 6 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 1 major shareholder and 1 chief executive.

The most recent open-market purchase was published on 28 September 2026, 43 days ago.

For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 7 filings here. Since 2021, the database holds 46 purchases and 17 sales by insiders of the company.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
70
Thresholds
n/a
Buy Volume
€51M
46 ops. · all time
Sell Volume
€47M
17 ops. · all time

Who traded when

BuySale
원익홀딩스5 buys
이민경1 buy

Since the insiders bought

  • Filed 09 Jul 2026 · 124 days ago · €221k
    -8.2%
    Entry ₩2,155 · Close 30 Oct 2026 ₩1,979
  • Filed 15 Jun 2026 · 148 days ago · €59k
    -3.9%
    Entry ₩2,060 · Close 30 Oct 2026 ₩1,979

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 3,799 of 26,911 companies
70.9
score / 100
Value
68
Quality
74
FCF yld-40%
Earn yld50%
EV/EBITDA1.5x
ROE-7.8%
Gross mgn98%
Net mgn23%
Debt/EBITDA0.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩2,020
Analyst consensus
·
Income statement
Revenue₩81.7B
Gross profit₩80.1B98% margin
EBITDA₩27.7B34% margin
Net income₩19.2B-9.9% margin
Valuation
Beta0.35
Balance sheet & cash
Market cap₩39.2B
Total debt₩3.3B
Free Cash Flow-₩15.3B
Debt / Equity3%
Profitability & ownership
ROE-7.8%
ROA-3.8%
% insiders32.8%
% institutions0.0%
Last declaration on 28 September 2026
Declarations75 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    Related company / holdingExecutives(filed)
    €61kest.0DART
    41,474 sharesShareKRXDART:20260928000370
    Canonical exit: 27 Dec 2026 (T+90)
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    Related company / holdingExecutives(filed)
    €221kest.0DART
    185,000 sharesKRXDART:20260709000534
    Canonical exit: 7 Oct 2026 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    €52kest.0DART
    43,334 sharesShareKRXDART:20260709000501
    Canonical exit: 7 Oct 2026 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    €164kest.0DART
    141,666 sharesShareKRXDART:20260701000515
    Canonical exit: 29 Sept 2026 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    €35kest.0DART
    31,857 sharesKRXDART:20260615000427
    Canonical exit: 13 Sept 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    €59kest.0DART
    53,472 sharesShareKRXDART:20260615000279
    Canonical exit: 13 Sept 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Related company / holdingExecutives
    €64kest.0DART
    26,720 sharesKRXDART:20240709000438
  • ▲
    Related company / holdingExecutives
    €2,599est.0DART
    1,000 sharesKRXDART:20240612000295
    Canonical exit: 2 Sept 2024 (T+90)
  • ▼
    -Executives
    0DART
    ShareKRXDART:20240530000408
  • ▲
    Related company / holdingExecutives
    €2,718est.0DART
    1,000 sharesKRXDART:20240509000442
    Canonical exit: 1 Aug 2024 (T+90)
  • ▲
    Related company / holdingExecutives
    €3,264est.0DART
    1,000 sharesKRXDART:20231212000021
    Canonical exit: 6 Mar 2024 (T+90)
  • ▲
    Related company / holdingExecutives
    €3,755est.0DART
    1,000 sharesKRXDART:20230912000093
    Canonical exit: 7 Dec 2023 (T+90)
  • ▲
    Related company / holdingExecutives
    €4,931est.0DART
    1,000 sharesKRXDART:20230613000207
    Canonical exit: 10 Sept 2023 (T+90)
  • ▲
    Related company / holdingExecutives
    €4,851est.0DART
    1,000 sharesKRXDART:20230517000273
    Canonical exit: 15 Aug 2023 (T+90)
  • ▼
    -Executives
    0DART
    ShareKRXDART:20230517000278
  • ▼
    -Executives
    0DART
    ShareKRXDART:20230509000450
  • ▲
    Related company / holdingExecutives
    €4,948est.0DART
    1,000 sharesKRXDART:20230509000445
    Canonical exit: 1 Aug 2023 (T+90)
  • ▼
    -Executives(filed)
    0DART
    ShareKRXDART:20230502000626

25 of 75 declarations

About 케어랩스

Carelabs is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing technological solutions to enhance healthcare services.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations